Patents by Inventor Marc Wong

Marc Wong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220385546
    Abstract: Systems and processes for iteratively training a network training module are described herein. In various embodiments, the process includes: (1) retrieving bulk data comprising a plurality of a data types, (2) transforming the bulk data according to preconfigured classification values to generate network information data sets; (3) training a raw training module by iteratively processing each of the network information data sets through a raw training module to generate respective output classification values; (4) updating one or more classification values based on a comparison of the respective output classification values; (5) processing an input network information data set with a trained training module to generate a specific network constituent; and (6) modifying a display based on the plurality of classification values.
    Type: Application
    Filed: June 1, 2022
    Publication date: December 1, 2022
    Inventors: Marc Wong, Christina R. Petrosso, Joseph W. Hanna, David Trachtenberg
  • Publication number: 20220169675
    Abstract: The current invention reports a method for purifying an antibody by reducing the content of a host cell protein. The method employs a wash step with a low conductivity aqueous solution in an affinity chromatography.
    Type: Application
    Filed: May 24, 2021
    Publication date: June 2, 2022
    Applicants: Genentech, Inc., Hoffmann-La Roche Inc.
    Inventors: Paul MCDONALD, Richard ST. JOHN, Marc Wong, Roberto FALKENSTEIN, Wolfgang KOEHNLEIN, Klaus SCHWENDNER, Bernhard SPENSBERGER, Michael WIEDMANN, Frank ZETTL, Annika KLEINJANS, Carina KOPP, Benjamin TRAN, Ryan ERICKSON
  • Publication number: 20220135620
    Abstract: The present disclosure provides purification platforms comprising a depth filter step and/or a hydrophobic interaction chromatography (HIC) step and/or a MM-HIC/IEX chromatography step, and are useful for providing a method of reducing a hydrolytic enzyme activity rate of a composition obtained from said purification platforms. Also disclosed herein are methods of using the purification platforms described herein and compositions obtained therefrom, such as pharmaceutical compositions.
    Type: Application
    Filed: October 28, 2021
    Publication date: May 5, 2022
    Inventors: Alex SEAY, Marc WONG, Stephen WOON, Michael LEE, Stefanie KHOO, William O'DWYER, Eileen DUENAS, Yinges YIGZAW, Amy LIM
  • Patent number: 10690671
    Abstract: The present invention provides methods for producing disulfide oxidoreductase A (DsbA) and disulfide oxidoreductase C (DsbC) polypeptides at very high levels of purity. Also provided are ultrapure DsbA and DsbC and methods of using same, e.g., for use in immunoassays to show removal of DsbA and DsbC from biologics produced in bacteria.
    Type: Grant
    Filed: July 24, 2018
    Date of Patent: June 23, 2020
    Assignee: Genentech, Inc.
    Inventors: Marc Wong, Liliana T. Yee, Amy Lim, Chris B. Fong
  • Publication number: 20190202919
    Abstract: Provided herein are methods of purifying anti-c-met antibodies, compositions, and pharmaceutical formulations comprising purified anti-c-met antibodies, and methods of using the same.
    Type: Application
    Filed: June 27, 2018
    Publication date: July 4, 2019
    Applicant: Genentech, Inc.
    Inventors: Marc WONG, Jerome J. BILL, JR., Arick M. BROWN, Glen S. GIESE, Judy Fay-Chen HSII, Amy LIM, Josefine PERSSON, Asha N. RADHAMOHAN, Maricel RODRIGUEZ
  • Publication number: 20190056399
    Abstract: The present invention provides methods for producing disulfide oxidoreductase A (DsbA) and disulfide oxidoreductase C (DsbC) polypeptides at very high levels of purity. Also provided are ultrapure DsbA and DsbC and methods of using same, e.g., for use in immunoassays to show removal of DsbA and DsbC from biologics produced in bacteria.
    Type: Application
    Filed: July 24, 2018
    Publication date: February 21, 2019
    Applicant: Genentech, Inc.
    Inventors: Marc Wong, Liliana T. Yee, Amy Lim, Chris B. Fong
  • Patent number: 10073098
    Abstract: The present invention provides methods for producing disulfide oxidoreductase A (DsbA) and disulfide oxidoreductase C (DsbC) polypeptides at very high levels of purity. Also provided are ultrapure DsbA and DsbC and methods of using same, e.g., for use in immunoassays to show removal of DsbA and DsbC from biologics produced in bacteria.
    Type: Grant
    Filed: March 4, 2016
    Date of Patent: September 11, 2018
    Assignee: Genentech, Inc.
    Inventors: Marc Wong, Liliana T. Yee, Amy Lim, Chris B. Fong
  • Publication number: 20180186832
    Abstract: The current invention reports a method for purifying an antibody by reducing the content of a host cell protein. The method employs a wash step with a low conductivity aqueous solution in an affinity chromatography.
    Type: Application
    Filed: February 20, 2018
    Publication date: July 5, 2018
    Applicants: Genentech, Inc., Hoffmann-La Roche Inc
    Inventors: Paul MCDONALD, Richard ST. JOHN, Marc WONG, Roberto FALKENSTEIN, Wolfgang KOEHNLEIN, Klaus SCHWENDNER, Bernhard SPENSBERGER, Michael WIEDMANN, Frank ZETTL, Annika KLEINJANS, Carina KOPP, Benjamin TRAN, Ryan ERICKSON
  • Publication number: 20160370369
    Abstract: The present invention provides methods for producing disulfide oxidoreductase A (DsbA) and disulfide oxidoreductase C (DsbC) polypeptides at very high levels of purity. Also provided are ultrapure DsbA and DsbC and methods of using same, e.g., for use in immunoassays to show removal of DsbA and DsbC from biologics produced in bacteria.
    Type: Application
    Filed: March 4, 2016
    Publication date: December 22, 2016
    Inventors: Marc WONG, Liliana T. YEE, Amy LIM, Chris B. FONG
  • Publication number: 20150050275
    Abstract: Provided herein are methods of purifying anti-c-met antibodies, compositions and pharmaceutical formulations comprising purified anti-c-met antibodies, and methods of using the same.
    Type: Application
    Filed: October 10, 2014
    Publication date: February 19, 2015
    Applicant: GENENTECH, INC.
    Inventors: Marc Wong, Jerome Joseph Bill, JR., Arick Michael Brown, Glen Scott Giese, Judy Fay-Chen Hsii, Amy Lim, Josefine Persson, Asha Nandini Radhamohan, Maricel Rodriguez